How Often Do You Have to Get Allergy Shots? Commitment Explained

A 30-minute post-injection observation is the traditional in-clinic standard, set by AAAAI and ACAAI practice parameters, because systemic allergic reactions — including rare anaphylaxis — can occur at any point in treatment, and the reaction window peaks in the first 20-30 minutes after injection. That biology does not change at home, which is exactly why an at-home program such as Curex builds the safeguards around it: a board-certified allergist confirms you are an eligible maintenance candidate, a prescribed epinephrine auto-injector is verified on hand before your first dose, and your first injection and every dose change are supervised live over Zoom. Eligible patients are trained to self-observe for the post-dose window and to keep emergency care reachable. The observation itself is never skipped — the change is that for stable maintenance doses it no longer requires sitting in a clinic.

Missing a build-up injection by more than 7 days triggers a mandatory dose reduction — typically about 50% of your last dose — and the escalation schedule restarts from that reduced level. Per Cox et al. (JACI 2011), this adds roughly 2-4 weeks to your build-up timeline for each missed dose. Missing 2 weeks or more during build-up may require restarting from a lower vial. These reductions are safety measures: your immune system's tolerance of the previous dose needs refreshing. If you know a gap is coming — due to travel, illness, or scheduling — notify your allergist in advance so they can prepare a dose-adjusted vial and minimize the schedule disruption.

Adherence data shows only 50-70% of patients complete 3 or more years of allergy shots, and some studies report as few as 23% completing the full recommended 3-5 year course. The primary reason: scheduling burden. The weekly build-up visits are the highest-dropout period — patients who manage build-up often discontinue during the early maintenance phase, when symptoms have partially improved and the perceived benefit feels less urgent than the ongoing inconvenience. Kiel et al. (JACI 2013) found drop-off peaks between months 6-18. Contributing factors include copay costs, employer schedule constraints, and travel. Strategies that improve adherence include flexible evening hours, automated appointment reminders, and early patient education on the long-term disease-modification goal.

Yes, it is possible to receive allergy shots while traveling, but it requires coordination. Your allergen extract vial is typically kept at your home allergist's office; to receive shots elsewhere, you need a temporary vial transfer or a prescription for a travel vial to bring to a cooperating practice. Not all allergist offices will administer shots using another practice's extract, so it is important to plan this well in advance — ideally at least 2-4 weeks before any extended trip. Some patients schedule extra shots before a trip to extend the gap, which is generally safe during the stable maintenance phase but not recommended during active build-up escalation.

Missing a maintenance injection by more than 4-6 weeks typically requires a dose reduction before resuming, per Cox et al. (JACI 2011). The specific adjustment depends on the gap length: a 6-8 week gap may require returning to 50-75% of the maintenance dose; a gap of 3 months or more may require partial re-escalation from an earlier build-up dose. The concern is that your immune tolerance level has partially declined during the gap, making the full maintenance dose potentially risky. For patients who have been on stable maintenance for 2+ years, longer gaps are sometimes tolerated with more lenient protocols, but this should always be assessed by your allergist with a vial test if there is any uncertainty.

Children follow essentially the same build-up frequency as adults — 1-2 visits per week — though some pediatric allergists prefer a slightly slower escalation for younger children to minimize distress from reactions. Maintenance frequency for children is often kept at biweekly (every 2 weeks) rather than monthly, at least during the first year, to allow closer monitoring of tolerability. The 30-minute post-injection observation period applies equally to children. The overall treatment duration — 3-5 years — is the same. The PAT study (Jacobsen et al., Allergy 2007) found that completing a 3-year course of SCIT in children with grass pollen allergy significantly reduced the risk of developing asthma over the following 7 years.

Several aspects of the allergy shot schedule offer real flexibility. The specific day of the week and time of your appointment are entirely your choice — no clinical evidence links specific days to better outcomes. The maintenance interval has a 2-week window: anything from every 2 weeks to every 4 weeks is protocol-compliant, so you have scheduling latitude of up to 14 days on either side of your nominal date. Cluster protocols can compress the build-up phase from 3-6 months to 4-8 weeks if your allergist offers this option. Once you have been stable on maintenance for a year or more, some allergists will extend intervals to 5-6 weeks for established patients.